173 related articles for article (PubMed ID: 38165326)
1. Association Between Hippocampal Volumes and Cognition in Cerebral Amyloid Angiopathy.
Perosa V; Zanon Zotin MC; Schoemaker D; Sveikata L; Etherton MR; Charidimou A; Greenberg SM; Viswanathan A
Neurology; 2024 Jan; 102(2):e207854. PubMed ID: 38165326
[TBL] [Abstract][Full Text] [Related]
2. Mediators of cognitive impairment in cerebral amyloid angiopathy.
Durrani R; Wang M; Cox E; Irving E; Saad F; McCreary CR; Beaudin AE; Gee M; Nelles K; Sajobi TT; Ismail Z; Camicioli R; Smith EE
Int J Stroke; 2023 Jan; 18(1):78-84. PubMed ID: 35473418
[TBL] [Abstract][Full Text] [Related]
3. Peak width of skeletonized mean diffusivity in cerebral amyloid angiopathy: Spatial signature, cognitive, and neuroimaging associations.
Zanon Zotin MC; Schoemaker D; Raposo N; Perosa V; Bretzner M; Sveikata L; Li Q; van Veluw SJ; Horn MJ; Etherton MR; Charidimou A; Gurol ME; Greenberg SM; Duering M; Dos Santos AC; Pontes-Neto OM; Viswanathan A
Front Neurosci; 2022; 16():1051038. PubMed ID: 36440281
[TBL] [Abstract][Full Text] [Related]
4. Peak Width of Skeletonized Mean Diffusivity as Neuroimaging Biomarker in Cerebral Amyloid Angiopathy.
Raposo N; Zanon Zotin MC; Schoemaker D; Xiong L; Fotiadis P; Charidimou A; Pasi M; Boulouis G; Schwab K; Schirmer MD; Etherton MR; Gurol ME; Greenberg SM; Duering M; Viswanathan A
AJNR Am J Neuroradiol; 2021 May; 42(5):875-881. PubMed ID: 33664113
[TBL] [Abstract][Full Text] [Related]
5. Cross-sectional and longitudinal differences in peak skeletonized white matter mean diffusivity in cerebral amyloid angiopathy.
McCreary CR; Beaudin AE; Subotic A; Zwiers AM; Alvarez A; Charlton A; Goodyear BG; Frayne R; Smith EE
Neuroimage Clin; 2020; 27():102280. PubMed ID: 32521475
[TBL] [Abstract][Full Text] [Related]
6. Cerebral Amyloid Angiopathy Is Associated With Executive Dysfunction and Mild Cognitive Impairment.
Case NF; Charlton A; Zwiers A; Batool S; McCreary CR; Hogan DB; Ismail Z; Zerna C; Coutts SB; Frayne R; Goodyear B; Haffenden A; Smith EE
Stroke; 2016 Aug; 47(8):2010-6. PubMed ID: 27338926
[TBL] [Abstract][Full Text] [Related]
7. Peak width of skeletonized mean diffusivity and cognitive performance in cerebral amyloid angiopathy.
Horn MJ; Gokcal E; Becker JA; Das AS; Schwab K; Zanon Zotin MC; Goldstein JN; Rosand J; Viswanathan A; Polimeni JR; Duering M; Greenberg SM; Gurol ME
Front Neurosci; 2023; 17():1141007. PubMed ID: 37077322
[TBL] [Abstract][Full Text] [Related]
8. Cortical atrophy in patients with cerebral amyloid angiopathy: a case-control study.
Fotiadis P; van Rooden S; van der Grond J; Schultz A; Martinez-Ramirez S; Auriel E; Reijmer Y; van Opstal AM; Ayres A; Schwab KM; ; Hedden T; Rosand J; Viswanathan A; Wermer M; Terwindt G; Sperling RA; Polimeni JR; Johnson KA; van Buchem MA; Greenberg SM; Gurol ME
Lancet Neurol; 2016 Jul; 15(8):811-819. PubMed ID: 27180034
[TBL] [Abstract][Full Text] [Related]
9. Cognitive Profile and its Association with Neuroimaging Markers of Non-Demented Cerebral Amyloid Angiopathy Patients in a Stroke Unit.
Xiong L; Davidsdottir S; Reijmer YD; Shoamanesh A; Roongpiboonsopit D; Thanprasertsuk S; Martinez-Ramirez S; Charidimou A; Ayres AM; Fotiadis P; Gurol E; Blacker DL; Greenberg SM; Viswanathan A
J Alzheimers Dis; 2016 Mar; 52(1):171-8. PubMed ID: 27060947
[TBL] [Abstract][Full Text] [Related]
10. Glymphatic dysfunction correlates with severity of small vessel disease and cognitive impairment in cerebral amyloid angiopathy.
Xu J; Su Y; Fu J; Wang X; Nguchu BA; Qiu B; Dong Q; Cheng X
Eur J Neurol; 2022 Oct; 29(10):2895-2904. PubMed ID: 35712978
[TBL] [Abstract][Full Text] [Related]
11. Association of Long-Term Blood Pressure Variability with Cerebral Amyloid Angiopathy-related Brain Injury and Cognitive Decline.
Sveikata L; Zotin MCZ; Schoemaker D; Ma Y; Perosa V; Chokesuwattanaskul A; Charidimou A; Duering M; Gurol EM; Assal F; Greenberg SM; Viswanathan A
medRxiv; 2024 Feb; ():. PubMed ID: 38464316
[TBL] [Abstract][Full Text] [Related]
12. Diffusion tensor tractography of the fornix in cerebral amyloid angiopathy, mild cognitive impairment and Alzheimer's disease.
Shaikh I; Beaulieu C; Gee M; McCreary CR; Beaudin AE; Valdés-Cabrera D; Smith EE; Camicioli R
Neuroimage Clin; 2022; 34():103002. PubMed ID: 35413649
[TBL] [Abstract][Full Text] [Related]
13. Domain-specific neuropsychological investigation of CAA with and without intracerebral haemorrhage.
Chan E; Bonifacio GB; Harrison C; Banerjee G; Best JG; Sacks B; Harding N; Del Rocio Hidalgo Mas M; Jäger HR; Cipolotti L; Werring DJ
J Neurol; 2023 Dec; 270(12):6124-6132. PubMed ID: 37672105
[TBL] [Abstract][Full Text] [Related]
14. Association of Memory Impairment With Concomitant Tau Pathology in Patients With Cerebral Amyloid Angiopathy.
Schoemaker D; Charidimou A; Zanon Zotin MC; Raposo N; Johnson KA; Sanchez JS; Greenberg SM; Viswanathan A
Neurology; 2021 Apr; 96(15):e1975-e1986. PubMed ID: 33627498
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of amyloid β positivity in patients with probable cerebral amyloid angiopathy markers.
Jang H; Jang YK; Kim HJ; Werring DJ; Lee JS; Choe YS; Park S; Lee J; Kim KW; Kim Y; Cho SH; Kim SE; Kim SJ; Charidimou A; Na DL; Seo SW
Eur J Nucl Med Mol Imaging; 2019 Jun; 46(6):1287-1298. PubMed ID: 30937462
[TBL] [Abstract][Full Text] [Related]
16. Role of White Matter Abnormalities in the Relationship Between Microbleed Burden and Cognitive Impairment in Cerebral Amyloid Angiopathy.
Jo S; Cheong EN; Kim N; Oh JS; Shim WH; Kim HJ; Lee SJ; Lee Y; Oh M; Kim JS; Kim BJ; Roh JH; Kim SJ; Lee JH
J Alzheimers Dis; 2022; 86(2):667-678. PubMed ID: 35124637
[TBL] [Abstract][Full Text] [Related]
17. Cerebral Amyloid Angiopathy in Amyloid-Positive Patients from a Memory Clinic Cohort.
Costa AS; Pinho J; Kučikienė D; Reich A; Schulz JB; Reetz K
J Alzheimers Dis; 2021; 79(4):1661-1672. PubMed ID: 33492291
[TBL] [Abstract][Full Text] [Related]
18. Total Magnetic Resonance Imaging Burden of Small Vessel Disease in Cerebral Amyloid Angiopathy: An Imaging-Pathologic Study of Concept Validation.
Charidimou A; Martinez-Ramirez S; Reijmer YD; Oliveira-Filho J; Lauer A; Roongpiboonsopit D; Frosch M; Vashkevich A; Ayres A; Rosand J; Gurol ME; Greenberg SM; Viswanathan A
JAMA Neurol; 2016 Aug; 73(8):994-1001. PubMed ID: 27366898
[TBL] [Abstract][Full Text] [Related]
19. Imaging markers of cerebral amyloid angiopathy and hypertensive arteriopathy differentiate Alzheimer disease subtypes synergistically.
Chen TB; Lee WJ; Chen JP; Chang SY; Lin CF; Chen HC
Alzheimers Res Ther; 2022 Sep; 14(1):141. PubMed ID: 36180874
[TBL] [Abstract][Full Text] [Related]
20. Cortical Thickness and Its Association with Clinical Cognitive and Neuroimaging Markers in Cerebral Amyloid Angiopathy.
Subotic A; McCreary CR; Saad F; Nguyen A; Alvarez-Veronesi A; Zwiers AM; Charlton A; Beaudin AE; Ismail Z; Pike GB; Smith EE
J Alzheimers Dis; 2021; 81(4):1663-1671. PubMed ID: 33998545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
